Mark Leonard Singleton - 15 Feb 2026 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: SVP & CFO
Signature: /s/ Anthony D'Adamio, Attorney-in-Fact
Issuer symbol: BVS
Transactions as of: 15 Feb 2026
Net transactions value: -$77,978
Form type: 4
Filing time: 18 Feb 2026, 18:30:05 UTC
Previous filing: 15 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Singleton Mark Leonard	SVP & CFO	4721 EMPEROR BOULEVARD, SUITE 100, DURHAM	/s/ Anthony D'Adamio, Attorney-in-Fact	18 Feb 2026	0001914936

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BVS	Class A Common Stock	Options Exercise	$0	+20,153	+14%	$0.000000	161,241	15 Feb 2026	Direct
transaction	BVS	Class A Common Stock	Tax liability	$77,978	-9,429	-5.8%	$8.27	151,812	15 Feb 2026	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BVS	Restricted Stock Units	Options Exercise	$0	-20,153	-33%	$0.000000	40,304	15 Feb 2026	Class A Common Stock	20,153		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2	The RSUs vest in four approximately equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date.